doi: 10.1016/0006-291x(90)92068-b.
Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts
Affiliations
- PMID: 2157410
- DOI: 10.1016/0006-291x(90)92068-b
Item in Clipboard
Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts
Biochem Biophys Res Commun.
.
Abstract
The activity of neutral sphingomyelinase (EC 3.1.4.12) in a plasma membrane enriched fraction was found to be increased in dexamethasone treated cells. The elevation of sphingomyelinase activity was blocked by cycloheximide indicating that protein synthesis was required for the steroid action. Ceramidase (EC3.5.1.23) activity was unaffected by the dexamethasone treatment. Levels of sphingosine in 3T3-L1 Cells were also increased after treatment with 10(-7) M dexamethasone for 2 and 4 hours.
Similar articles
-
A neutral sphingomyelinase in spermatozoal plasma membranes.Biochem Cell Biol. 1987 Jun;65(6):525-8. doi: 10.1139/o87-067. Biochem Cell Biol. 1987. PMID: 2827708
-
Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is oriented externally on the plasma membrane.Biochim Biophys Acta. 1984 Nov 7;777(2):339-42. doi: 10.1016/0005-2736(84)90437-1. Biochim Biophys Acta. 1984. PMID: 6091759
-
Localization of neutral magnesium-stimulated sphingomyelinase in plasma membrane of cultured neuroblastoma cells.Biochim Biophys Acta. 1982 Oct 28;719(1):162-4. doi: 10.1016/0304-4165(82)90321-x. Biochim Biophys Acta. 1982. PMID: 6293585 No abstract available.
-
The subcellular localization of neutral sphingomyelinase in rat liver.J Lipid Res. 1979 May;20(4):456-63. J Lipid Res. 1979. PMID: 37279
-
Halothane increases membrane fluidity and stimulates sphingomyelin degradation by membrane-bound neutral sphingomyelinase of synaptosomal plasma membranes from calf brain already at clinical concentrations.J Neurochem. 1980 Apr;34(4):988-92. doi: 10.1111/j.1471-4159.1980.tb09675.x. J Neurochem. 1980. PMID: 6244368 No abstract available.
Cited by
-
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.Endocr Rev. 2008 Jun;29(4):381-402. doi: 10.1210/er.2007-0025. Epub 2008 May 1. Endocr Rev. 2008. PMID: 18451260 Free PMC article. Review.
-
Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model.EMBO Mol Med. 2014 Mar;6(3):398-413. doi: 10.1002/emmm.201302649. Epub 2014 Jan 21. EMBO Mol Med. 2014. PMID: 24448491 Free PMC article.
-
Sphingolipid metabolites: members of a new class of lipid second messengers.J Membr Biol. 1995 Aug;146(3):225-37. doi: 10.1007/BF00233943. J Membr Biol. 1995. PMID: 8568838 Review. No abstract available.
-
Neutral sphingomyelinase in physiological and measles virus induced T cell suppression.PLoS Pathog. 2014 Dec 18;10(12):e1004574. doi: 10.1371/journal.ppat.1004574. eCollection 2014 Dec. PLoS Pathog. 2014. PMID: 25521388 Free PMC article.
-
The role of skeletal muscle sphingolipids in the development of insulin resistance.Rev Diabet Stud. 2008 Spring;5(1):13-24. doi: 10.1900/RDS.2008.5.13. Epub 2008 May 10. Rev Diabet Stud. 2008. PMID: 18548166 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
